Clinical Trial Update: Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) [Phase 3]

View source ↗

Summary

A Phase 3 trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Ciprofloxacin dry powder for inhalation (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Bronchiectasis | Phase 3 | Status: COMPLETED | Results posted: 2017-09-01